Skip to main content

«  View All Posts

Growing Our Impact in 2022

July 25th, 2022 | 1 min. read

By Christina Thiry

Total RX and KLAS logo inside Everside E logo

Published: July 25, 2022

Our team continues to challenge the broken model of fee-for-service health care in 2022. Instead of patient quotas and costly referrals that support a profit-driven system, we’ve found that real health care means affordable costs, convenient access, more time with a doctor, and advanced technology that supports our patients. This type of health care - our type of health care - is having a real impact and 2022 is looking to be our most impactful year yet. 

Over the last 7 months, we’ve opened 28 new health centers nationwide. We’ve launched a brand-new service, TotalRx, that saves employers’ and patients’ time and money on their prescriptions, all while making medication management easier and more accessible. We expanded our mental health services for our union members in the St. Louis region, meaning thousands of Everside patients now have access to virtual mental health support for concerns including anxiety, depression, substance abuse, and more. 

We were also honored to win the 2022 ‘Best in KLAS’ award for Employer Sponsored Healthcare Services Provider, while our CEO, Chris Miller, was recently awarded EY’s Entrepreneur of the Year award for the Mountain West region. 

All of this makes our latest news even more exciting. 

Today, we are announcing that we’ve raised $164 million in funding from new and existing partners, including New Enterprise Associates (NEA), Oak HC/FT, Alta Partners, and Endeavor Catalyst. This endorsement is especially meaningful as it enables us to bring our essential and effective care to even more Americans and allows us to further expand our services, advance our technology, including our predictive patient care system, and sustainably fuel our growth. 

We’re changing what “health care as usual” means, and we are honored to share this journey with our partners by continuing to always be by your side. To learn more about our funding, you can view our press release here.